{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:27:57Z","timestamp":1793384877999,"version":"4.5.0"},"reference-count":150,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T00:00:00Z","timestamp":1525392000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s11255-018-1873-2","type":"journal-article","created":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T13:25:53Z","timestamp":1525440353000},"page":"1453-1466","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":142,"title":["The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus"],"prefix":"10.1007","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1297-0675","authenticated-orcid":false,"given":"Mehmet","family":"Kanbay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emine M.","family":"Onal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baris","family":"Afsar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuncay","family":"Dagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aslihan","family":"Yerlikaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Covic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nosratola D.","family":"Vaziri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,4]]},"reference":[{"key":"1873_CR1","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nature11550","volume":"489","author":"CA Lozupone","year":"2012","unstructured":"Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R (2012) Diversity, stability and resilience of the human gut microbiota. Nature 489:220\u2013230","journal-title":"Nature"},{"key":"1873_CR2","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1146\/annurev.mi.31.100177.000543","volume":"31","author":"DC Savage","year":"1977","unstructured":"Savage DC (1977) Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol 31:107\u2013133","journal-title":"Annu Rev Microbiol"},{"key":"1873_CR3","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/ndt\/gfv353","volume":"31","author":"A Yoshifuji","year":"2016","unstructured":"Yoshifuji A, Wakino S, Irie J, Tajima T, Hasegawa K, Kanda T, Tokuyama H, Hayashi K, Itoh H (2016) Gut Lactobacillus protects against the progression of renal damage by modulating the gut environment in rats. Nephrol Dial Transplant 31:401\u2013412","journal-title":"Nephrol Dial Transplant"},{"key":"1873_CR4","doi-asserted-by":"publisher","first-page":"1468s1475s","DOI":"10.3945\/jn.116.240754","volume":"147","author":"L Wen","year":"2017","unstructured":"Wen L, Duffy A (2017) Factors influencing the gut microbiota, inflammation, and type 2 diabetes. J Nutr 147:1468s\u20131475s","journal-title":"J Nutr"},{"key":"1873_CR5","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/ismej.2009.5","volume":"3","author":"LF Roesch","year":"2009","unstructured":"Roesch LF, Lorca GL, Casella G, Giongo A, Naranjo A, Pionzio AM, Li N, Mai V, Wasserfall CH, Schatz D, Atkinson MA, Neu J, Triplett EW (2009) Culture-independent identification of gut bacteria correlated with the onset of diabetes in a rat model. ISME J 3:536\u2013548","journal-title":"ISME J"},{"key":"1873_CR6","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1161\/HYPERTENSIONAHA.115.05315","volume":"65","author":"T Yang","year":"2015","unstructured":"Yang T, Santisteban MM, Rodriguez V, Li E, Ahmari N, Carvajal JM, Zadeh M, Gong M, Qi Y, Zubcevic J, Sahay B, Pepine CJ, Raizada MK, Mohamadzadeh M (2015) Gut dysbiosis is linked to hypertension. Hypertension 65:1331\u20131340","journal-title":"Hypertension"},{"key":"1873_CR7","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/hdi.12486","volume":"21","author":"T Khoury","year":"2017","unstructured":"Khoury T, Tzukert K, Abel R, Abu Rmeileh A, Levi R, Ilan Y (2017) The gut-kidney axis in chronic renal failure: a new potential target for therapy. Hemodial Int 21:323\u2013334","journal-title":"Hemodial Int"},{"key":"1873_CR8","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.2215\/CJN.13121215","volume":"11","author":"RL Amdur","year":"2016","unstructured":"Amdur RL, Feldman HI, Gupta J, Yang W, Kanetsky P, Shlipak M, Rahman M, Lash JP, Townsend RR, Ojo A, Roy-Chaudhury A, Go AS, Joffe M, He J, Balakrishnan VS, Kimmel PL, Kusek JW, Raj DS (2016) Inflammation and progression of CKD: the CRIC Study. Clin J Am Soc Nephrol 11:1546\u20131556","journal-title":"Clin J Am Soc Nephrol"},{"key":"1873_CR9","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s00467-008-1046-0","volume":"24","author":"DM Silverstein","year":"2009","unstructured":"Silverstein DM (2009) Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease. Pediatr Nephrol 24:1445\u20131452","journal-title":"Pediatr Nephrol"},{"key":"1873_CR10","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1097\/MIB.0b013e31829e13e1","volume":"19","author":"B Lewis","year":"2013","unstructured":"Lewis B, Mukewar S, Lopez R, Brzezinski A, Hall P, Shen B (2013) Frequency and risk factors of renal insufficiency in inflammatory bowel disease inpatients. Inflamm Bowel Dis 19:1846\u20131851","journal-title":"Inflamm Bowel Dis"},{"key":"1873_CR11","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/apt.13236","volume":"42","author":"C Cas\u00e9n","year":"2015","unstructured":"Cas\u00e9n C, Veb\u00f8 HC, Sekelja M, Hegge FT, Karlsson MK, Ciemniejewska E, Dzankovic S, Fr\u00f8yland C, Nestestog R, Engstrand L, Munkholm P, Nielsen OH, Rogler G, Simr\u00e9n M, \u00d6hman L, Vatn MH, Rudi K (2015) Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD. Aliment Pharmacol Ther 42:71\u201383","journal-title":"Aliment Pharmacol Ther"},{"key":"1873_CR12","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/ki.2012.345","volume":"83","author":"ND Vaziri","year":"2013","unstructured":"Vaziri ND, Wong J, Pahl M, Piceno YM, Yuan J, DeSantis TZ, Ni Z, Nguyen TH, Andersen GL (2013) Chronic kidney disease alters intestinal microbial flora. Kidney Int 83:308\u2013315","journal-title":"Kidney Int"},{"key":"1873_CR13","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.biopha.2017.06.066","volume":"93","author":"F Mahmoodpoor","year":"2017","unstructured":"Mahmoodpoor F, Rahbar Saadat Y, Barzegari A, Ardalan M, Zununi Vahed S (2017) The impact of gut microbiota on kidney function and pathogenesis. Biomed Pharmacother 93:412\u2013419","journal-title":"Biomed Pharmacother"},{"key":"1873_CR14","doi-asserted-by":"publisher","first-page":"164","DOI":"10.15252\/embr.201439263","volume":"16","author":"HE Jakobsson","year":"2015","unstructured":"Jakobsson HE, Rodriguez-Pineiro AM, Schutte A, Ermund A, Boysen P, Bemark M, Sommer F, Backhed F, Hansson GC, Johansson ME (2015) The composition of the gut microbiota shapes the colon mucus barrier. EMBO Rep 16:164\u2013177","journal-title":"EMBO Rep"},{"key":"1873_CR15","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3389\/fimmu.2015.00639","volume":"6","author":"S Omenetti","year":"2015","unstructured":"Omenetti S, Pizarro TT (2015) The Treg\/Th17 axis: a dynamic balance regulated by the gut microbiome. Front Immunol 6:639","journal-title":"Front Immunol"},{"key":"1873_CR16","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1007\/s10620-014-3202-7","volume":"59","author":"K Shi","year":"2014","unstructured":"Shi K, Wang F, Jiang H, Liu H, Wei M, Wang Z, Xie L (2014) Gut bacterial translocation may aggravate microinflammation in hemodialysis patients. Dig Dis Sci 59:2109\u20132117","journal-title":"Dig Dis Sci"},{"key":"1873_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1093\/ndt\/gft367","volume":"29","author":"J Poveda","year":"2014","unstructured":"Poveda J, Sanchez-Nino MD, Glorieux G, Sanz AB, Egido J, Vanholder R, Ortiz A (2014) p-Cresyl sulphate has pro-inflammatory and cytotoxic actions on human proximal tubular epithelial cells. Nephrol Dial Transplant 29:56\u201364","journal-title":"Nephrol Dial Transplant"},{"key":"1873_CR18","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1159\/000360010","volume":"39","author":"J Wong","year":"2014","unstructured":"Wong J, Piceno YM, DeSantis TZ, Pahl M, Andersen GL, Vaziri ND (2014) Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD. Am J Nephrol 39:230\u2013237","journal-title":"Am J Nephrol"},{"key":"1873_CR19","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1194\/jlr.R500013-JLR200","volume":"47","author":"JM Ridlon","year":"2006","unstructured":"Ridlon JM, Kang DJ, Hylemon PB (2006) Bile salt biotransformations by human intestinal bacteria. J Lipid Res 47:241\u2013259","journal-title":"J Lipid Res"},{"key":"1873_CR20","doi-asserted-by":"publisher","first-page":"3558","DOI":"10.1096\/fj.14-262493","volume":"29","author":"LD Truong","year":"2015","unstructured":"Truong LD, Trostel J, Garcia GE (2015) Absence of nicotinic acetylcholine receptor alpha7 subunit amplifies inflammation and accelerates onset of fibrosis: an inflammatory kidney model. FASEB J 29:3558\u20133570","journal-title":"FASEB J"},{"key":"1873_CR21","doi-asserted-by":"publisher","first-page":"G807G819","DOI":"10.1152\/ajpgi.00243.2009","volume":"298","author":"CL Ohland","year":"2010","unstructured":"Ohland CL, Macnaughton WK (2010) Probiotic bacteria and intestinal epithelial barrier function. Am J Physiol Gastrointest Liver Physiol 298:G807\u2013G819","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1873_CR22","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/j.1365-2672.2012.05344.x","volume":"113","author":"E Barrett","year":"2012","unstructured":"Barrett E, Ross RP, O\u2019Toole PW, Fitzgerald GF, Stanton C (2012) gamma-Aminobutyric acid production by culturable bacteria from the human intestine. J Appl Microbiol 113:411\u2013417","journal-title":"J Appl Microbiol"},{"key":"1873_CR23","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.freeradbiomed.2006.06.020","volume":"41","author":"T Sobko","year":"2006","unstructured":"Sobko T, Huang L, Midtvedt T, Norin E, Gustafsson LE, Norman M, Jansson EA, Lundberg JO (2006) Generation of NO by probiotic bacteria in the gastrointestinal tract. Free Radic Biol Med 41:985\u2013991","journal-title":"Free Radic Biol Med"},{"key":"1873_CR24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1476-9255-11-11","volume":"11","author":"JAA Andrade de","year":"2014","unstructured":"de Andrade JAA, Gayer CRM, Nogueira NPA, Paes MC, Bastos V, Neto J, Alves SC Jr, Coelho RM, da Cunha M, Gomes RN, Aguila MB, Mandarim-de-Lacerda CA, Bozza PT, da Cunha S (2014) The effect of thiamine deficiency on inflammation, oxidative stress and cellular migration in an experimental model of sepsis. J Inflamm (Lond) 11:11","journal-title":"J Inflamm (Lond)"},{"key":"1873_CR25","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s11154-014-9288-6","volume":"15","author":"A Everard","year":"2014","unstructured":"Everard A, Cani PD (2014) Gut microbiota and GLP-1. Rev Endocr Metab Disord 15:189\u2013196","journal-title":"Rev Endocr Metab Disord"},{"key":"1873_CR26","doi-asserted-by":"publisher","first-page":"16050","DOI":"10.1073\/pnas.1102999108","volume":"108","author":"JA Bravo","year":"2011","unstructured":"Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, Bienenstock J, Cryan JF (2011) Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci USA 108:16050\u201316055","journal-title":"Proc Natl Acad Sci USA"},{"key":"1873_CR27","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/ndt\/gfv095","volume":"31","author":"ND Vaziri","year":"2016","unstructured":"Vaziri ND, Zhao YY, Pahl MV (2016) Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatment. Nephrol Dial Transplant 31:737\u2013746","journal-title":"Nephrology Dial Transplant"},{"key":"1873_CR28","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/pr.2014.159","volume":"77","author":"N Uy","year":"2015","unstructured":"Uy N, Graf L, Lemley K, Kaskel F (2015) Effects of gluten-free, dairy-free diet on childhood nephrotic syndrome and gut microbiota. Pediatr Res 77:252\u2013255","journal-title":"Pediatr Res"},{"key":"1873_CR29","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s40168-017-0300-8","volume":"5","author":"Q Mu","year":"2017","unstructured":"Mu Q, Zhang H, Liao X, Lin K, Liu H, Edwards MR, Ahmed SA, Yuan R, Li L, Cecere TE, Branson DB, Kirby JL, Goswami P, Leeth CM, Read KA, Oestreich KJ, Vieson MD, Reilly CM, Luo XM (2017) Control of lupus nephritis by changes of gut microbiota. Microbiome 5:73","journal-title":"Microbiome"},{"key":"1873_CR30","doi-asserted-by":"publisher","first-page":"e5842","DOI":"10.1371\/journal.pone.0005842","volume":"4","author":"CS Reigstad","year":"2009","unstructured":"Reigstad CS, Lunden GO, Felin J, Backhed F (2009) Regulation of serum amyloid A3 (SAA3) in mouse colonic epithelium and adipose tissue by the intestinal microbiota. PLoS ONE 4:e5842","journal-title":"PLoS ONE"},{"key":"1873_CR31","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1128\/AEM.66.4.1654-1661.2000","volume":"66","author":"A Barcenilla","year":"2000","unstructured":"Barcenilla A, Pryde SE, Martin JC, Duncan SH, Stewart CS, Henderson C, Flint HJ (2000) Phylogenetic relationships of butyrate-producing bacteria from the human gut. Appl Environ Microbiol 66:1654\u20131661","journal-title":"Appl Environ Microbiol"},{"key":"1873_CR32","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40168-016-0222-x","volume":"5","author":"J Li","year":"2017","unstructured":"Li J, Zhao F, Wang Y, Chen J, Tao J, Tian G, Wu S, Liu W, Cui Q, Geng B, Zhang W, Weldon R, Auguste K, Yang L, Liu X, Chen L, Yang X, Zhu B, Cai J (2017) Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome 5:14","journal-title":"Microbiome"},{"key":"1873_CR33","doi-asserted-by":"publisher","first-page":"523","DOI":"10.4103\/2230-8210.183474","volume":"20","author":"P Pushpanathan","year":"2016","unstructured":"Pushpanathan P, Srikanth P, Seshadri KG, Selvarajan S, Pitani RS, Kumar TD, Janarthanan R (2016) Gut microbiota in type 2 diabetes individuals and correlation with monocyte chemoattractant protein1 and interferon gamma from patients attending a Tertiary Care Centre in Chennai, India. Indian J Endocrinol Metab 20:523\u2013530","journal-title":"Indian J Endocrinol Metab"},{"key":"1873_CR34","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1128\/IAI.63.1.333-339.1995","volume":"63","author":"FR Kohn","year":"1995","unstructured":"Kohn FR, Kung AH (1995) Role of endotoxin in acute inflammation induced by gram-negative bacteria: specific inhibition of lipopolysaccharide-mediated responses with an amino-terminal fragment of bactericidal\/permeability-increasing protein. Infect Immun 63:333\u2013339","journal-title":"Infect Immun"},{"key":"1873_CR35","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nm.3145","volume":"19","author":"RA Koeth","year":"2013","unstructured":"Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, Britt EB, Fu X, Wu Y, Li L, Smith JD, DiDonato JA, Chen J, Li H, Wu GD, Lewis JD, Warrier M, Brown JM, Krauss RM, Tang WH, Bushman FD, Lusis AJ, Hazen SL (2013) Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 19:576\u2013585","journal-title":"Nat Med"},{"key":"1873_CR36","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1126\/science.1198469","volume":"331","author":"K Atarashi","year":"2011","unstructured":"Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, Cheng G, Yamasaki S, Saito T, Ohba Y, Taniguchi T, Takeda K, Hori S, Ivanov II, Umesaki Y, Itoh K, Honda K (2011) Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331:337\u2013341","journal-title":"Science"},{"key":"1873_CR37","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1093\/ndt\/gfs133","volume":"28","author":"CY Sun","year":"2013","unstructured":"Sun CY, Hsu HH, Wu MS (2013) p-Cresol sulfate and indoxyl sulfate induce similar cellular inflammatory gene expressions in cultured proximal renal tubular cells. Nephrol Dial Transplant 28:70\u201378","journal-title":"Nephrol Dial Transplant"},{"key":"1873_CR38","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1161\/CIRCRESAHA.116.305360","volume":"116","author":"WH Tang","year":"2015","unstructured":"Tang WH, Wang Z, Kennedy DJ, Wu Y, Buffa JA, Agatisa-Boyle B, Li XS, Levison BS, Hazen SL (2015) Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ Res 116:448\u2013455","journal-title":"Circ Res"},{"key":"1873_CR39","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1681\/ASN.2009070696","volume":"20","author":"T Toyohara","year":"2009","unstructured":"Toyohara T, Suzuki T, Morimoto R, Akiyama Y, Souma T, Shiwaku HO, Takeuchi Y, Mishima E, Abe M, Tanemoto M, Masuda S, Kawano H, Maemura K, Nakayama M, Sato H, Mikkaichi T, Yamaguchi H, Fukui S, Fukumoto Y, Shimokawa H, Inui K-i, Terasaki T, Goto J, Ito S, Hishinuma T, Rubera I, Tauc M, Fujii-Kuriyama Y, Yabuuchi H, Moriyama Y, Soga T, Abe T (2009) SLCO4C1 transporter eliminates uremic toxins and attenuates hypertension and renal inflammation. J Am Soc Nephrol 20:2546\u20132555","journal-title":"J Am Soc Nephrol"},{"key":"1873_CR40","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1159\/000046026","volume":"88","author":"K Okada","year":"2001","unstructured":"Okada K, Takahashi Y, Okawa E, Onishi Y, Hagi C, Aoki K, Shibahara H, Higuchi T, Nagura Y, Kanmatsuse K, Takahashi S (2001) Relationship between insulin resistance and uremic toxins in the gastrointestinal tract. Nephron 88:384\u2013386","journal-title":"Nephron"},{"key":"1873_CR41","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1073\/pnas.0906112107","volume":"107","author":"T Bansal","year":"2010","unstructured":"Bansal T, Alaniz RC, Wood TK, Jayaraman A (2010) The bacterial signal indole increases epithelial-cell tight-junction resistance and attenuates indicators of inflammation. Proc Natl Acad Sci USA 107:228\u2013233","journal-title":"Proc Natl Acad Sci USA"},{"key":"1873_CR42","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1021\/acs.jafc.6b00656","volume":"64","author":"X Wong","year":"2016","unstructured":"Wong X, Carrasco-Pozo C, Escobar E, Navarrete P, Blachier F, Andriamihaja M, Lan A, Tom\u00e9 D, Cires MJ, Pastene E, Gotteland M (2016) Deleterious effect of p-cresol on human colonic epithelial cells prevented by proanthocyanidin-containing polyphenol extracts from fruits and proanthocyanidin bacterial metabolites. J Agric Food Chem 64:3574\u20133583","journal-title":"J Agric Food Chem"},{"key":"1873_CR43","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1161\/HYPERTENSIONAHA.115.06672","volume":"67","author":"DJ Durgan","year":"2016","unstructured":"Durgan DJ, Ganesh BP, Cope JL, Ajami NJ, Phillips SC, Petrosino JF, Hollister EB, Bryan RM (2016) Role of the gut microbiome in obstructive sleep apnea-induced hypertension. Hypertension 67:469\u2013474","journal-title":"Hypertension"},{"key":"1873_CR44","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1152\/physiolgenomics.00081.2016","volume":"49","author":"S Adnan","year":"2017","unstructured":"Adnan S, Nelson JW, Ajami NJ, Venna VR, Petrosino JF, Bryan RM, Durgan DJ (2017) Alterations in the gut microbiota can elicit hypertension in rats. Physiol Genom 49:96","journal-title":"Physiol Genom"},{"key":"1873_CR45","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1161\/CIRCRESAHA.116.309006","volume":"120","author":"MM Santisteban","year":"2017","unstructured":"Santisteban MM, Qi Y, Zubcevic J, Kim S, Yang T, Shenoy V, Cole-Jeffrey CT, Lobaton GO, Stewart DC, Rubiano A, Simmons CS, Garcia-Pereira F, Johnson RD, Pepine CJ, Raizada MK (2017) Hypertension-linked pathophysiological alterations in the gut. Circ Res 120:312\u2013323","journal-title":"Circ Res"},{"key":"1873_CR46","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1023\/B:DDAS.0000026302.92898.ae","volume":"49","author":"EA Griffiths","year":"2004","unstructured":"Griffiths EA, Duffy LC, Schanbacher FL, Qiao H, Dryja D, Leavens A, Rossman J, Rich G, Dirienzo D, Ogra PL (2004) In vivo effects of bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in Balb\/c mice. Dig Dis Sci 49:579\u2013589","journal-title":"Dig Dis Sci"},{"key":"1873_CR47","doi-asserted-by":"publisher","DOI":"10.1152\/physiolgenomics.00089.2016","author":"N Natarajan","year":"2016","unstructured":"Natarajan N, Hori D, Flavahan S, Steppan J, Flavahan NA, Berkowitz DE, Pluznick JL (2016) Microbial short chain fatty acid metabolites lower blood pressure via endothelial G-protein coupled receptor 41. Physiol Genom. https:\/\/doi.org\/10.1152\/physiolgenomics.00089.2016","journal-title":"Physiol Genom"},{"key":"1873_CR48","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1093\/ajh\/hpu117","volume":"28","author":"SP Juraschek","year":"2015","unstructured":"Juraschek SP, Bower JK, Selvin E, Subash Shantha GP, Hoogeveen RC, Ballantyne CM, Young JH (2015) Plasma lactate and incident hypertension in the atherosclerosis risk in communities study. Am J Hypertens 28:216\u2013224","journal-title":"Am J Hypertens"},{"key":"1873_CR49","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1096\/fj.00-0359fje","volume":"14","author":"MD Saemann","year":"2000","unstructured":"Saemann MD, Bohmig GA, Osterreicher CH, Burtscher H, Parolini O, Diakos C, Stockl J, Horl WH, Zlabinger GJ (2000) Anti-inflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL-12 and up-regulation of IL-10 production. FASEB J 14:2380\u20132382","journal-title":"FASEB J"},{"key":"1873_CR50","doi-asserted-by":"publisher","first-page":"E1289E1295","DOI":"10.1152\/ajpendo.00373.2007","volume":"293","author":"A Basu","year":"2007","unstructured":"Basu A, Charkoudian N, Schrage W, Rizza RA, Basu R, Joyner MJ (2007) Beneficial effects of GLP-1 on endothelial function in humans: dampening by glyburide but not by glimepiride. Am J Physiol Endocrinol Metab 293:E1289\u2013E1295","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1873_CR51","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1024\/0301-1526\/a000404","volume":"44","author":"WD Ito","year":"2015","unstructured":"Ito WD, Lund N, Sager H, Becker W, Wenzel U (2015) Differential impact of diabetes mellitus type II and arterial hypertension on collateral artery growth and concomitant macrophage accumulation. Vasa 44:31\u201341","journal-title":"Vasa"},{"key":"1873_CR52","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1213\/ane.0b013e3181884bbf","volume":"107","author":"KX Liu","year":"2008","unstructured":"Liu KX, Chen SQ, Huang WQ, Li YS, Irwin MG, Xia Z (2008) Propofol pretreatment reduces ceramide production and attenuates intestinal mucosal apoptosis induced by intestinal ischemia\/reperfusion in rats. Anesth Analg 107:1884\u20131891","journal-title":"Anesth Analg"},{"key":"1873_CR53","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/SHK.0b013e3182940cb8","volume":"39","author":"F Wang","year":"2013","unstructured":"Wang F, Li Q, He Q, Geng Y, Tang C, Wang C, Li J (2013) Temporal variations of the ileal microbiota in intestinal ischemia and reperfusion. Shock 39:96\u2013103","journal-title":"Shock"},{"key":"1873_CR54","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jaut.2014.03.005","volume":"53","author":"J Peng","year":"2014","unstructured":"Peng J, Narasimhan S, Marchesi JR, Benson A, Wong FS, Wen L (2014) Long term effect of gut microbiota transfer on diabetes development. J Autoimmun 53:85\u201394","journal-title":"J Autoimmun"},{"key":"1873_CR55","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1053\/j.gastro.2012.06.031","volume":"143","author":"A Vrieze","year":"2012","unstructured":"Vrieze A, Van Nood E, Holleman F, Salojarvi J, Kootte RS, Bartelsman JF, Dallinga-Thie GM, Ackermans MT, Serlie MJ, Oozeer R, Derrien M, Druesne A, Van Hylckama Vlieg JE, Bloks VW, Groen AK, Heilig HG, Zoetendal EG, Stroes ES, de Vos WM, Hoekstra JB, Nieuwdorp M (2012) Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143:913\u2013916.e917","journal-title":"Gastroenterology"},{"key":"1873_CR56","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1007\/s00125-006-0465-3","volume":"49","author":"E Bosi","year":"2006","unstructured":"Bosi E, Molteni L, Radaelli MG, Folini L, Fermo I, Bazzigaluppi E, Piemonti L, Pastore MR, Paroni R (2006) Increased intestinal permeability precedes clinical onset of type 1 diabetes. Diabetologia 49:2824\u20132827","journal-title":"Diabetologia"},{"key":"1873_CR57","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1136\/gut.2008.165886","volume":"58","author":"PD Cani","year":"2009","unstructured":"Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, Geurts L, Naslain D, Neyrinck A, Lambert DM, Muccioli GG, Delzenne NM (2009) Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58:1091\u20131103","journal-title":"Gut"},{"key":"1873_CR58","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1099\/ijs.0.02345-0","volume":"53","author":"J Kopecny","year":"2003","unstructured":"Kopecny J, Zorec M, Mrazek J, Kobayashi Y, Marinsek-Logar R (2003) Butyrivibrio hungatei sp. nov. and Pseudobutyrivibrio xylanivorans sp. nov., butyrate-producing bacteria from the rumen. Int J Syst Evol Microbiol 53:201\u2013209","journal-title":"Int J Syst Evol Microbiol"},{"key":"1873_CR59","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature11450","volume":"490","author":"J Qin","year":"2012","unstructured":"Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, Liang S, Zhang W, Guan Y, Shen D, Peng Y, Zhang D, Jie Z, Wu W, Qin Y, Xue W, Li J, Han L, Lu D, Wu P, Dai Y, Sun X, Li Z, Tang A, Zhong S, Li X, Chen W, Xu R, Wang M, Feng Q, Gong M, Yu J, Zhang Y, Zhang M, Hansen T, Sanchez G, Raes J, Falony G, Okuda S, Almeida M, LeChatelier E, Renault P, Pons N, Batto J-M, Zhang Z, Chen H, Yang R, Zheng W, Li S, Yang H, Wang J, Ehrlich SD, Nielsen R, Pedersen O, Kristiansen K, Wang J (2012) A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490:55\u201360","journal-title":"Nature"},{"key":"1873_CR60","doi-asserted-by":"publisher","first-page":"e25792","DOI":"10.1371\/journal.pone.0025792","volume":"6","author":"CT Brown","year":"2011","unstructured":"Brown CT, Davis-Richardson AG, Giongo A, Gano KA, Crabb DB, Mukherjee N, Casella G, Drew JC, Ilonen J, Knip M, Hyoty H, Veijola R, Simell T, Simell O, Neu J, Wasserfall CH, Schatz D, Atkinson MA, Triplett EW (2011) Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS ONE 6:e25792","journal-title":"PLoS ONE"},{"key":"1873_CR61","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1079\/PNS19960090","volume":"55","author":"A Hague","year":"1996","unstructured":"Hague A, Butt AJ, Paraskeva C (1996) The role of butyrate in human colonic epithelial cells: an energy source or inducer of differentiation and apoptosis? Proc Nutr Soc 55:937\u2013943","journal-title":"Proc Nutr Soc"},{"key":"1873_CR62","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.3945\/jn.109.104638","volume":"139","author":"L Peng","year":"2009","unstructured":"Peng L, Li Z-R, Green RS, Holzman IR, Lin J (2009) Butyrate Enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in caco-2 cell monolayers. J Nutr 139:1619\u20131625","journal-title":"J Nutr"},{"key":"1873_CR63","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1042\/BJ20082222","volume":"420","author":"N Burger-van Paassen","year":"2009","unstructured":"Burger-van Paassen N, Vincent A, Puiman PJ, van der Sluis M, Bouma J, Boehm G, van Goudoever JB, van Seuningen I, Renes IB (2009) The regulation of intestinal mucin MUC2 expression by short-chain fatty acids: implications for epithelial protection. Biochem J 420:211\u2013219","journal-title":"Biochem J"},{"key":"1873_CR64","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1093\/ajcn\/76.5.1117","volume":"76","author":"B Deplancke","year":"2002","unstructured":"Deplancke B, Vidal O, Ganessunker D, Donovan SM, Mackie RI, Gaskins HR (2002) Selective growth of mucolytic bacteria including Clostridium perfringens in a neonatal piglet model of total parenteral nutrition. Am J Clin Nutr 76:1117\u20131125","journal-title":"Am J Clin Nutr"},{"key":"1873_CR65","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.1128\/JB.182.11.3002-3007.2000","volume":"182","author":"DP Wright","year":"2000","unstructured":"Wright DP, Knight CG, Parkar SG, Christie DL, Roberton AM (2000) Cloning of a mucin-desulfating sulfatase gene from prevotella strain RS2 and its expression using a bacteroides recombinant system. J Bacteriol 182:3002\u20133007","journal-title":"J Bacteriol"},{"key":"1873_CR66","first-page":"183","volume-title":"The enteric toxins of Clostridium perfringens. Reviews of physiology, biochemistry and pharmacology","author":"JG Smedley","year":"2005","unstructured":"Smedley JG, Fisher DJ, Sayeed S, Chakrabarti G, McClane BA (2005) The enteric toxins of Clostridium perfringens. Reviews of physiology, biochemistry and pharmacology. Springer, Berlin, pp\u00a0183\u2013204"},{"key":"1873_CR67","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.2337\/db06-1491","volume":"56","author":"PD Cani","year":"2007","unstructured":"Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, Waget A, Delm\u00e9e E, Cousin B, Sulpice T, Chamontin B, Ferri\u00e8res J, Tanti J-F, Gibson GR, Casteilla L, Delzenne NM, Alessi MC, Burcelin R (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56:1761","journal-title":"Diabetes"},{"key":"1873_CR68","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.2337\/dc09-0467","volume":"32","author":"M Nymark","year":"2009","unstructured":"Nymark M, Pussinen PJ, Tuomainen AM, Forsblom C, Groop P-H, Lehto M, On behalf of the FinnDiane Study Group (2009) Serum lipopolysaccharide activity is associated with the progression of kidney disease in finnish patients with type 1 diabetes. Diabetes Care 32:1689\u20131693","journal-title":"Diabetes Care"},{"key":"1873_CR69","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1084\/jem.20160526","volume":"213","author":"N Tai","year":"2016","unstructured":"Tai N, Peng J, Liu F, Gulden E, Hu Y, Zhang X, Chen L, Wong FS, Wen L (2016) Microbial antigen mimics activate diabetogenic CD8 T cells in NOD mice. J Exp Med 213:2129\u20132146","journal-title":"J Exp Med"},{"key":"1873_CR70","doi-asserted-by":"publisher","first-page":"7569431","DOI":"10.1155\/2016\/7569431","volume":"2016","author":"J Dolpady","year":"2016","unstructured":"Dolpady J, Sorini C, Di Pietro C, Cosorich I, Ferrarese R, Saita D, Clementi M, Canducci F, Falcone M (2016) Oral probiotic VSL#3 prevents autoimmune diabetes by modulating microbiota and promoting indoleamine 2,3-dioxygenase-enriched tolerogenic intestinal environment. J Diabetes Res 2016:7569431","journal-title":"J Diabetes Res"},{"key":"1873_CR71","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1126\/science.1206095","volume":"332","author":"JL Round","year":"2011","unstructured":"Round JL, Lee SM, Li J, Tran G, Jabri B, Chatila TA, Mazmanian SK (2011) The Toll-like receptor pathway establishes commensal gut colonization. Science 332:974\u2013977","journal-title":"Science"},{"key":"1873_CR72","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature12721","volume":"504","author":"Y Furusawa","year":"2013","unstructured":"Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, Nakanishi Y, Uetake C, Kato K, Kato T, Takahashi M, Fukuda NN, Murakami S, Miyauchi E, Hino S, Atarashi K, Onawa S, Fujimura Y, Lockett T, Clarke JM, Topping DL, Tomita M, Hori S, Ohara O, Morita T, Koseki H, Kikuchi J, Honda K, Hase K, Ohno H (2013) Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504:446\u2013450","journal-title":"Nature"},{"key":"1873_CR73","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1111\/j.1365-2672.2011.05157.x","volume":"111","author":"JG LeBlanc","year":"2011","unstructured":"LeBlanc JG, Laino JE, del Valle MJ, Vannini V, van Sinderen D, Taranto MP, de Valdez GF, de Giori GS, Sesma F (2011) B-group vitamin production by lactic acid bacteria\u2014current knowledge and potential applications. J Appl Microbiol 111:1297\u20131309","journal-title":"J Appl Microbiol"},{"key":"1873_CR74","first-page":"83","volume":"2","author":"S Jayashree","year":"2010","unstructured":"Jayashree S, Jayaraman K, Kalaichelvan G (2010) Isolation, screening and characterization of riboflavin producing lactic acid bacteria from Katpadi, Vellore district. Recent Res Sci Technol 2:83\u201388","journal-title":"Recent Res Sci Technol"},{"key":"1873_CR75","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/nature11605","volume":"491","author":"L Kjer-Nielsen","year":"2012","unstructured":"Kjer-Nielsen L, Patel O, Corbett AJ, Le Nours J, Meehan B, Liu L, Bhati M, Chen Z, Kostenko L, Reantragoon R, Williamson NA, Purcell AW, Dudek NL, McConville MJ, O\u2018Hair RAJ, Khairallah GN, Godfrey DI, Fairlie DP, Rossjohn J, McCluskey J (2012) MR1 presents microbial vitamin B metabolites to MAIT cells. Nature 491:717\u2013723","journal-title":"Nature"},{"key":"1873_CR76","first-page":"762","volume":"59","author":"X Ruijing","year":"2012","unstructured":"Ruijing X, Mengjun W, Xiaoling Z, Shu P, Mei W, Yingcheng Z, Yuling H, Jinquan T (2012) Jalpha33 + MAIT cells play a protective role in TNBS induced intestinal inflammation. Hepatogastroenterology 59:762\u2013767","journal-title":"Hepatogastroenterology"},{"key":"1873_CR77","doi-asserted-by":"publisher","first-page":"3694957","DOI":"10.1155\/2016\/3694957","volume":"2016","author":"Y-c Qiao","year":"2016","unstructured":"Qiao Y-c, Shen J, He L, Hong X-z, Tian F, Pan Y-h, Liang L, Zhang X-x, Zhao H-l (2016) Changes of regulatory T cells and of proinflammatory and immunosuppressive cytokines in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. J Diabetes Res 2016:3694957","journal-title":"J Diabetes Res"},{"key":"1873_CR78","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.2337\/db10-1201","volume":"60","author":"E Badami","year":"2011","unstructured":"Badami E, Sorini C, Coccia M, Usuelli V, Molteni L, Bolla AM, Scavini M, Mariani A, King C, Bosi E, Falcone M (2011) Defective differentiation of regulatory FoxP3(+) T cells by small-intestinal dendritic cells in patients with type 1 diabetes. Diabetes 60:2120\u20132124","journal-title":"Diabetes"},{"key":"1873_CR79","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/ni.3730","volume":"18","author":"L Wen","year":"2017","unstructured":"Wen L, Wong FS (2017) Dietary short-chain fatty acids protect against type 1 diabetes. Nat Immunol 18:484\u2013486","journal-title":"Nat Immunol"},{"key":"1873_CR80","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1530\/JME-14-0065","volume":"53","author":"G Shi","year":"2014","unstructured":"Shi G, Sun C, Gu W, Yang M, Zhang X, Zhai N, Lu Y, Zhang Z, Shou P, Zhang Z, Ning G (2014) Free fatty acid receptor 2, a candidate target for type 1 diabetes, induces cell apoptosis through ERK signaling. J Mol Endocrinol 53:367\u2013380","journal-title":"J Mol Endocrinol"},{"key":"1873_CR81","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.2337\/db14-1938","volume":"64","author":"JC McNelis","year":"2015","unstructured":"McNelis JC, Lee YS, Mayoral R, van der Kant R, Johnson AM, Wollam J, Olefsky JM (2015) GPR43 potentiates beta-cell function in obesity. Diabetes 64:3203\u20133217","journal-title":"Diabetes"},{"key":"1873_CR82","first-page":"549","volume":"85","author":"CS Venter","year":"1990","unstructured":"Venter CS, Vorster HH, Cummings JH (1990) Effects of dietary propionate on carbohydrate and lipid metabolism in healthy volunteers. Am J Gastroenterol 85:549\u2013553","journal-title":"Am J Gastroenterol"},{"key":"1873_CR83","doi-asserted-by":"publisher","first-page":"28159","DOI":"10.1038\/srep28159","volume":"6","author":"SR Villa","year":"2016","unstructured":"Villa SR, Priyadarshini M, Fuller MH, Bhardwaj T, Brodsky MR, Angueira AR, Mosser RE, Carboneau BA, Tersey SA, Mancebo H, Gilchrist A, Mirmira RG, Gannon M, Layden BT (2016) Loss of free fatty acid receptor 2 leads to impaired islet mass and beta cell survival. Sci Rep 6:28159","journal-title":"Sci Rep"},{"key":"1873_CR84","doi-asserted-by":"publisher","first-page":"364","DOI":"10.2337\/db11-1019","volume":"61","author":"G Tolhurst","year":"2012","unstructured":"Tolhurst G, Heffron H, Lam YS, Parker HE, Habib AM, Diakogiannaki E, Cameron J, Grosse J, Reimann F, Gribble FM (2012) Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes 61:364\u2013371","journal-title":"Diabetes"},{"key":"1873_CR85","doi-asserted-by":"publisher","first-page":"580","DOI":"10.2337\/diacare.19.6.580","volume":"19","author":"WO Creutzfeldt","year":"1996","unstructured":"Creutzfeldt WO, Kleine N, Willms B, Orskov C, Holst JJ, Nauck MA (1996) Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I (7-36) amide in type I diabetic patients. Diabetes Care 19:580\u2013586","journal-title":"Diabetes Care"},{"key":"1873_CR86","doi-asserted-by":"publisher","first-page":"412","DOI":"10.2174\/15733998113099990070","volume":"9","author":"P Grigoropoulou","year":"2013","unstructured":"Grigoropoulou P, Eleftheriadou I, Zoupas C, Diamanti-Kandarakis E, Tentolouris N (2013) Incretin-based therapies for type 2 diabetes mellitus: effects on insulin resistance. Curr Diabetes Rev 9:412\u2013417","journal-title":"Curr Diabetes Rev"},{"key":"1873_CR87","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2337\/diabetes.53.1.5","volume":"53","author":"GG Holz","year":"2004","unstructured":"Holz GG (2004) Epac: a new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cell. Diabetes 53:5\u201313","journal-title":"Diabetes"},{"key":"1873_CR88","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3727\/096368908785096060","volume":"17","author":"L Cobianchi","year":"2008","unstructured":"Cobianchi L, Fornoni A, Pileggi A, Molano RD, Sanabria NY, Gonzalez-Quintana J, Bocca N, Marzorati S, Zahr E, Hogan AR, Ricordi C, Inverardi L (2008) Riboflavin inhibits IL-6 expression and p38 activation in islet cells. Cell Transplant 17:559\u2013566","journal-title":"Cell Transplant"},{"key":"1873_CR89","doi-asserted-by":"publisher","first-page":"5298","DOI":"10.4049\/jimmunol.173.8.5298","volume":"173","author":"J Tian","year":"2004","unstructured":"Tian J, Lu Y, Zhang H, Chau CH, Dang HN, Kaufman DL (2004) Gamma-aminobutyric acid inhibits T cell autoimmunity and the development of inflammatory responses in a mouse type 1 diabetes model. J Immunol 173:5298\u20135304","journal-title":"J Immunol"},{"key":"1873_CR90","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3920\/BM2015.0154","volume":"7","author":"TM Marques","year":"2016","unstructured":"Marques TM, Patterson E, Wall R, O\u2019Sullivan O, Fitzgerald GF, Cotter PD, Dinan TG, Cryan JF, Ross RP, Stanton C (2016) Influence of GABA and GABA-producing Lactobacillus brevis DPC 6108 on the development of diabetes in a streptozotocin rat model. Benef Microbes 7:409\u2013420","journal-title":"Benef Microbes"},{"key":"1873_CR91","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s00210-012-0794-3","volume":"385","author":"A Joshi","year":"2012","unstructured":"Joshi A, Woodman OL (2012) Increased nitric oxide activity compensates for increased oxidative stress to maintain endothelial function in rat aorta in early type 1 diabetes. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 385:1083\u20131094","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"1873_CR92","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.sjbs.2015.09.027","volume":"23","author":"BA Aldahmash","year":"2016","unstructured":"Aldahmash BA, El-Nagar DM, Ibrahim KE (2016) Attenuation of hepatotoxicity and oxidative stress in diabetes STZ-induced type 1 by biotin in Swiss albino mice. Saudi J Biol Sci 23:311\u2013317","journal-title":"Saudi J Biol Sci"},{"key":"1873_CR93","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jpeds.2012.12.055","volume":"163","author":"AS Pe\u00f1a","year":"2013","unstructured":"Pe\u00f1a AS, Maftei O, Dowling K, Gent R, Wiltshire E, MacKenzie K, Couper J (2013) Folate fortification and supplementation do not provide vascular health benefits in type 1 diabetes. J Pediatr 163:255\u2013260","journal-title":"J Pediatr"},{"key":"1873_CR94","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.2337\/db10-0019","volume":"59","author":"XX Wang","year":"2010","unstructured":"Wang XX, Jiang T, Shen Y, Caldas Y, Miyazaki-Anzai S, Santamaria H, Urbanek C, Solis N, Scherzer P, Lewis L, Gonzalez FJ, Adorini L, Pruzanski M, Kopp JB, Verlander JW, Levi M (2010) Diabetic nephropathy is accelerated by farnesoid X receptor deficiency and inhibited by farnesoid X receptor activation in a type 1 diabetes model. Diabetes 59:2916\u20132927","journal-title":"Diabetes"},{"key":"1873_CR95","first-page":"25","volume":"34","author":"C Zhu","year":"2016","unstructured":"Zhu C, Fuchs CD, Halilbasic E, Trauner M (2016) Bile acids in regulation of inflammation and immunity: friend or foe? Clin Exp Rheumatol 34:25\u201331","journal-title":"Clin Exp Rheumatol"},{"key":"1873_CR96","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1177\/0192623313505929","volume":"42","author":"DM Moynes","year":"2014","unstructured":"Moynes DM, Lucas GH, Beyak MJ, Lomax AE (2014) Effects of inflammation on the innervation of the colon. Toxicol Pathol 42:111\u2013117","journal-title":"Toxicol Pathol"},{"key":"1873_CR97","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/BF00399929","volume":"35","author":"DG Bruce","year":"1992","unstructured":"Bruce DG, Chisholm DJ, Storlien LH, Kraegen EW, Smythe GA (1992) The effects of sympathetic nervous system activation and psychological stress on glucose metabolism and blood pressure in subjects with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 35:835\u2013843","journal-title":"Diabetologia"},{"key":"1873_CR98","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.bbi.2016.07.151","volume":"57","author":"JE Beilharz","year":"2016","unstructured":"Beilharz JE, Kaakoush NO, Maniam J, Morris MJ (2016) The effect of short-term exposure to energy-matched diets enriched in fat or sugar on memory, gut microbiota and markers of brain inflammation and plasticity. Brain Behav Immun 57:304\u2013313","journal-title":"Brain Behav Immun"},{"key":"1873_CR99","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1172\/JCI8273","volume":"106","author":"CC Watkins","year":"2000","unstructured":"Watkins CC, Sawa A, Jaffrey S, Blackshaw S, Barrow RK, Snyder SH, Ferris CD (2000) Insulin restores neuronal nitric oxide synthase expression and function that is lost in diabetic gastropathy. J Clin Invest 106:373\u2013384","journal-title":"J Clin Invest"},{"key":"1873_CR100","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.2337\/diabetes.49.10.1731","volume":"49","author":"T Ordog","year":"2000","unstructured":"Ordog T, Takayama I, Cheung WK, Ward SM, Sanders KM (2000) Remodeling of networks of interstitial cells of cajal in a murine model of diabetic gastroparesis. Diabetes 49:1731\u20131739","journal-title":"Diabetes"},{"key":"1873_CR101","first-page":"530","volume":"24","author":"M Virally-Monod","year":"1998","unstructured":"Virally-Monod M, Tielmans D, Kevorkian JP, Bouhnik Y, Flourie B, Porokhov B, Ajzenberg C, Warnet A, Guillausseau PJ (1998) Chronic diarrhoea and diabetes mellitus: prevalence of small intestinal bacterial overgrowth. Diabetes Metab 24:530\u2013536","journal-title":"Diabetes Metab"},{"key":"1873_CR102","doi-asserted-by":"publisher","first-page":"33251","DOI":"10.1038\/srep33251","volume":"6","author":"L Wang","year":"2016","unstructured":"Wang L, Li P, Tang Z, Yan X, Feng B (2016) Structural modulation of the gut microbiota and the relationship with body weight: compared evaluation of liraglutide and saxagliptin treatment. Sci Rep 6:33251","journal-title":"Sci Rep"},{"key":"1873_CR103","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.bbrc.2017.09.108","volume":"493","author":"G Sun","year":"2017","unstructured":"Sun G, Yin Z, Liu N, Bian X, Yu R, Su X, Zhang B, Wang Y (2017) Gut microbial metabolite TMAO contributes to renal dysfunction in a mouse model of diet-induced obesity. Biochem Biophys Res Commun 493:964\u2013970","journal-title":"Biochem Biophys Res Commun"},{"key":"1873_CR104","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1159\/000452453","volume":"135","author":"B Wu","year":"2017","unstructured":"Wu B, Jiang H, He Q, Wang M, Xue J, Liu H, Shi K, Wei M, Liang S, Zhang L (2017) Liquid chromatography\/mass spectrometry reveals the effect of lactobacillus treatment on the faecal metabolite profile of rats with chronic renal failure. Nephron 135:156\u2013166","journal-title":"Nephron"},{"key":"1873_CR105","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1161\/CIRCULATIONAHA.116.024545","volume":"135","author":"FZ Marques","year":"2017","unstructured":"Marques FZ, Nelson E, Chu PY, Horlock D, Fiedler A, Ziemann M, Tan JK, Kuruppu S, Rajapakse NW, El-Osta A, Mackay CR, Kaye DM (2017) High-fiber diet and acetate supplementation change the gut microbiota and prevent the development of hypertension and heart failure in hypertensive mice. Circulation 135:964\u2013977","journal-title":"Circulation"},{"key":"1873_CR106","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.actbio.2016.08.045","volume":"45","author":"DC Stewart","year":"2016","unstructured":"Stewart DC, Rubiano A, Santisteban MM, Shenoy V, Qi Y, Pepine CJ, Raizada MK, Simmons CS (2016) Hypertension-linked mechanical changes of rat gut. Acta Biomater 45:296\u2013302","journal-title":"Acta Biomater"},{"key":"1873_CR107","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3920\/BM2016.0167","volume":"8","author":"X Li","year":"2017","unstructured":"Li X, Wang E, Yin B, Fang D, Chen P, Wang G, Zhao J, Zhang H, Chen W (2017) Effects of Lactobacillus casei CCFM419 on insulin resistance and gut microbiota in type 2 diabetic mice. Benef Microbes 8:421\u2013432","journal-title":"Benef Microbes"},{"key":"1873_CR108","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3920\/BM2016.0090","volume":"8","author":"S Singh","year":"2017","unstructured":"Singh S, Sharma RK, Malhotra S, Pothuraju R, Shandilya UK (2017) Lactobacillus rhamnosus NCDC17 ameliorates type-2 diabetes by improving gut function, oxidative stress and inflammation in high-fat-diet fed and streptozotocintreated rats. Benef Microbes 8:243\u2013255","journal-title":"Benef Microbes"},{"key":"1873_CR109","doi-asserted-by":"publisher","first-page":"e0184789","DOI":"10.1371\/journal.pone.0184789","volume":"12","author":"R Yacoub","year":"2017","unstructured":"Yacoub R, Nugent M, Cai W, Nadkarni GN, Chaves LD, Abyad S, Honan AM, Thomas SA, Zheng W, Valiyaparambil SA, Bryniarski MA, Sun Y, Buck M, Genco RJ, Quigg RJ, He JC, Uribarri J (2017) Advanced glycation end products dietary restriction effects on bacterial gut microbiota in peritoneal dialysis patients; a randomized open label controlled trial. PLoS ONE 12:e0184789","journal-title":"PLoS ONE"},{"key":"1873_CR110","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2215\/CJN.05240515","volume":"11","author":"M Rossi","year":"2016","unstructured":"Rossi M, Johnson DW, Morrison M, Pascoe EM, Coombes JS, Forbes JM, Szeto CC, McWhinney BC, Ungerer JP, Campbell KL (2016) Synbiotics easing renal failure by improving gut microbiology (SYNERGY): a randomized trial. Clin J Am Soc Nephrol 11:223\u2013231","journal-title":"Clin J Am Soc Nephrol"},{"key":"1873_CR111","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-1967","author":"D Fangmann","year":"2017","unstructured":"Fangmann D, Theismann EM, Turk K, Schulte DM, Relling I, Hartmann K, Keppler JK, Knipp JR, Rehman A, Heinsen FA, Franke A, Lenk L, Freitag-Wolf S, Appel E, Gorb S, Brenner C, Seegert D, Waetzig GH, Rosenstiel P, Schreiber S, Schwarz K, Laudes M (2017) Targeted microbiome intervention by microencapsulated delayed-release niacin beneficially affects insulin sensitivity in humans. Diabetes Care. https:\/\/doi.org\/10.2337\/dc17-1967","journal-title":"Diabetes Care"},{"key":"1873_CR112","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.kint.2016.09.040","volume":"91","author":"A Soleimani","year":"2017","unstructured":"Soleimani A, Zarrati Mojarrad M, Bahmani F, Taghizadeh M, Ramezani M, Tajabadi-Ebrahimi M, Jafari P, Esmaillzadeh A, Asemi Z (2017) Probiotic supplementation in diabetic hemodialysis patients has beneficial metabolic effects. Kidney Int 91:435\u2013442","journal-title":"Kidney Int"},{"key":"1873_CR113","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12944-016-0245-0","volume":"15","author":"M Balfego","year":"2016","unstructured":"Balfego M, Canivell S, Hanzu FA, Sala-Vila A, Martinez-Medina M, Murillo S, Mur T, Ruano EG, Linares F, Porras N, Valladares S, Fontalba M, Roura E, Novials A, Hernandez C, Aranda G, Siso-Almirall A, Rojo-Martinez G, Simo R, Gomis R (2016) Effects of sardine-enriched diet on metabolic control, inflammation and gut microbiota in drug-naive patients with type 2 diabetes: a pilot randomized trial. Lipids Health Dis 15:78","journal-title":"Lipids Health Dis"},{"key":"1873_CR114","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1056\/NEJMoa0907355","volume":"362","author":"K Bibbins-Domingo","year":"2010","unstructured":"Bibbins-Domingo K, Chertow GM, Coxson PG, Moran A, Lightwood JM, Pletcher MJ, Goldman L (2010) Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med 362:590\u2013599","journal-title":"N Engl J Med"},{"key":"1873_CR115","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1126\/science.1208344","volume":"334","author":"GD Wu","year":"2011","unstructured":"Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, Bewtra M, Knights D, Walters WA, Knight R, Sinha R, Gilroy E, Gupta K, Baldassano R, Nessel L, Li H, Bushman FD, Lewis JD (2011) Linking long-term dietary patterns with gut microbial enterotypes. Science 334:105\u2013108","journal-title":"Science"},{"key":"1873_CR116","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/j.1365-2036.2008.03911.x","volume":"29","author":"DB Silk","year":"2009","unstructured":"Silk DB, Davis A, Vulevic J, Tzortzis G, Gibson GR (2009) Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther 29:508\u2013518","journal-title":"Aliment Pharmacol Ther"},{"key":"1873_CR117","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1039\/C5FO01096A","volume":"7","author":"A Klinder","year":"2016","unstructured":"Klinder A, Shen Q, Heppel S, Lovegrove JA, Rowland I, Tuohy KM (2016) Impact of increasing fruit and vegetables and flavonoid intake on the human gut microbiota. Food Funct 7:1788\u20131796","journal-title":"Food Funct"},{"key":"1873_CR118","doi-asserted-by":"publisher","first-page":"e114881","DOI":"10.1371\/journal.pone.0114881","volume":"9","author":"ND Vaziri","year":"2014","unstructured":"Vaziri ND, Liu SM, Lau WL, Khazaeli M, Nazertehrani S, Farzaneh SH, Kieffer DA, Adams SH, Martin RJ (2014) High amylose resistant starch diet ameliorates oxidative stress, inflammation, and progression of chronic kidney disease. PLoS ONE 9:e114881","journal-title":"PLoS ONE"},{"key":"1873_CR119","doi-asserted-by":"publisher","first-page":"F857F871","DOI":"10.1152\/ajprenal.00513.2015","volume":"310","author":"DA Kieffer","year":"2016","unstructured":"Kieffer DA, Piccolo BD, Vaziri ND, Liu S, Lau WL, Khazaeli M, Nazertehrani S, Moore ME, Marco ML, Martin RJ, Adams SH (2016) Resistant starch alters gut microbiome and metabolomic profiles concurrent with amelioration of chronic kidney disease in rats. Am J Physiol Renal Physiol 310:F857\u2013F871","journal-title":"Am J Physiol Renal Physiol"},{"key":"1873_CR120","doi-asserted-by":"publisher","first-page":"712","DOI":"10.3945\/an.115.009654","volume":"6","author":"CK Richter","year":"2015","unstructured":"Richter CK, Skulas-Ray AC, Champagne CM, Kris-Etherton PM (2015) Plant protein and animal proteins: do they differentially affect cardiovascular disease risk? Adv Nutr 6:712\u2013728","journal-title":"Adv Nutr"},{"key":"1873_CR121","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/ki.2011.355","volume":"81","author":"VM Krishnamurthy","year":"2012","unstructured":"Krishnamurthy VM, Wei G, Baird BC, Murtaugh M, Chonchol MB, Raphael KL, Greene T, Beddhu S (2012) High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease. Kidney Int 81:300\u2013306","journal-title":"Kidney Int"},{"key":"1873_CR122","first-page":"222","volume":"68","author":"M Pavan","year":"2016","unstructured":"Pavan M (2016) Influence of prebiotic and probiotic supplementation on the progression of chronic kidney disease. Minerva Urol Nefrol 68:222\u2013226","journal-title":"Minerva Urol Nefrol"},{"key":"1873_CR123","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1017\/S0007114514003675","volume":"113","author":"A Aliasgharzadeh","year":"2015","unstructured":"Aliasgharzadeh A, Dehghan P, Gargari BP, Asghari-Jafarabadi M (2015) Resistant dextrin, as a prebiotic, improves insulin resistance and inflammation in women with type 2 diabetes: a randomised controlled clinical trial. Br J Nutr 113:321\u2013330","journal-title":"Br J Nutr"},{"key":"1873_CR124","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1093\/jn\/121.6.795","volume":"121","author":"I Torsdottir","year":"1991","unstructured":"Torsdottir I, Alpsten M, Holm G, Sandberg AS, Tolli J (1991) A small dose of soluble alginate-fiber affects postprandial glycemia and gastric emptying in humans with diabetes. J Nutr 121:795\u2013799","journal-title":"J Nutr"},{"key":"1873_CR125","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1093\/ajcn\/85.4.1157","volume":"85","author":"R Sola","year":"2007","unstructured":"Sola R, Godas G, Ribalta J, Vallve JC, Girona J, Anguera A, Ostos M, Recalde D, Salazar J, Caslake M, Martin-Lujan F, Salas-Salvado J, Masana L (2007) Effects of soluble fiber (Plantago ovata husk) on plasma lipids, lipoproteins, and apolipoproteins in men with ischemic heart disease. Am J Clin Nutr 85:1157\u20131163","journal-title":"Am J Clin Nutr"},{"key":"1873_CR126","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/00004872-199202000-00014","volume":"10","author":"K Eliasson","year":"1992","unstructured":"Eliasson K, Ryttig KR, Hylander B, Rossner S (1992) A dietary fibre supplement in the treatment of mild hypertension. A randomized, double-blind, placebo-controlled trial. J Hypertens 10:195\u2013199","journal-title":"J Hypertens"},{"key":"1873_CR127","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/00004872-200401000-00015","volume":"22","author":"J He","year":"2004","unstructured":"He J, Streiffer RH, Muntner P, Krousel-Wood MA, Whelton PK (2004) Effect of dietary fiber intake on blood pressure: a randomized, double-blind, placebo-controlled trial. J Hypertens 22:73\u201380","journal-title":"J Hypertens"},{"key":"1873_CR128","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1177\/1753425912456223","volume":"19","author":"HL Zhu","year":"2013","unstructured":"Zhu HL, Liu YL, Xie XL, Huang JJ, Hou YQ (2013) Effect of L-arginine on intestinal mucosal immune barrier function in weaned pigs after Escherichia coli LPS challenge. Innate Immun 19:242\u2013252","journal-title":"Innate Immun"},{"key":"1873_CR129","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.phymed.2015.10.018","volume":"23","author":"J Tome-Carneiro","year":"2016","unstructured":"Tome-Carneiro J, Visioli F (2016) Polyphenol-based nutraceuticals for the prevention and treatment of cardiovascular disease: review of human evidence. Phytomedicine 23:1145\u20131174","journal-title":"Phytomedicine"},{"key":"1873_CR130","first-page":"380","volume":"14","author":"JA Hawrelak","year":"2009","unstructured":"Hawrelak JA, Cattley T, Myers SP (2009) Essential oils in the treatment of intestinal dysbiosis: a preliminary in vitro study. Altern Med Rev 14:380\u2013384","journal-title":"Altern Med Rev"},{"key":"1873_CR131","doi-asserted-by":"publisher","first-page":"3831972","DOI":"10.1155\/2017\/3831972","volume":"2017","author":"V Monda","year":"2017","unstructured":"Monda V, Villano I, Messina A, Valenzano A, Esposito T, Moscatelli F, Viggiano A, Cibelli G, Chieffi S, Monda M, Messina G (2017) Exercise modifies the gut microbiota with positive health effects. Oxid Med Cell Longev 2017:3831972","journal-title":"Oxid Med Cell Longev"},{"key":"1873_CR132","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1097\/MPG.0b013e318263066c","volume":"55","author":"RJ Gobel","year":"2012","unstructured":"Gobel RJ, Larsen N, Jakobsen M, Molgaard C, Michaelsen KF (2012) Probiotics to adolescents with obesity: effects on inflammation and metabolic syndrome. J Pediatr Gastroenterol Nutr 55:673\u2013678","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1873_CR133","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1550-2783-9-45","volume":"9","author":"M Lamprecht","year":"2012","unstructured":"Lamprecht M, Bogner S, Schippinger G, Steinbauer K, Fankhauser F, Hallstroem S, Schuetz B, Greilberger JF (2012) Probiotic supplementation affects markers of intestinal barrier, oxidation, and inflammation in trained men; a randomized, double-blinded, placebo-controlled trial. J Int Soc Sports Nutr 9:45","journal-title":"J Int Soc Sports Nutr"},{"key":"1873_CR134","first-page":"582","volume":"29","author":"PV Miranda Alatriste","year":"2014","unstructured":"Miranda Alatriste PV, Urbina Arronte R, Gomez Espinosa CO, Espinosa Cuevas MDLA (2014) Effect of probiotics on human blood urea levels in patients with chronic renal failure. Nutr Hosp 29:582\u2013590","journal-title":"Nutr Hosp"},{"key":"1873_CR135","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1007\/s12325-010-0059-9","volume":"27","author":"N Ranganathan","year":"2010","unstructured":"Ranganathan N, Ranganathan P, Friedman EA, Joseph A, Delano B, Goldfarb DS, Tam P, Rao AV, Anteyi E, Musso CG (2010) Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease. Adv Ther 27:634\u2013647","journal-title":"Adv Ther"},{"key":"1873_CR136","first-page":"36","volume":"11","author":"B Abbasi","year":"2017","unstructured":"Abbasi B, Ghiasvand R, Mirlohi M (2017) Kidney function improvement by soy milk containing Lactobacillus plantarum A7 in type 2 diabetic patients with nephropathy: a double-blinded randomized controlled trial. Iran J Kidney Dis 11:36\u201343","journal-title":"Iran J Kidney Dis"},{"key":"1873_CR137","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1161\/HYPERTENSIONAHA.114.03469","volume":"64","author":"S Khalesi","year":"2014","unstructured":"Khalesi S, Sun J, Buys N, Jayasinghe R (2014) Effect of probiotics on blood pressure: a systematic review and meta-analysis of randomized, controlled trials. Hypertension 64:897\u2013903","journal-title":"Hypertension"},{"key":"1873_CR138","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12937-016-0127-3","volume":"15","author":"R Yacoub","year":"2016","unstructured":"Yacoub R, Kaji D, Patel SN, Simoes PK, Busayavalasa D, Nadkarni GN, He JC, Coca SG, Uribarri J (2016) Association between probiotic and yogurt consumption and kidney disease: insights from NHANES. Nutr J 15:10","journal-title":"Nutr J"},{"key":"1873_CR139","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1001\/jamapediatrics.2015.2757","volume":"170","author":"U Uusitalo","year":"2016","unstructured":"Uusitalo U, Liu X, Yang J, Aronsson CA, Hummel S, Butterworth M, Lernmark \u00c5, Rewers M, Hagopian W, She J-X, Simell O, Toppari J, Ziegler AG, Akolkar B, Krischer J, Norris JM, Virtanen SM (2016) Association of early exposure of probiotics and islet autoimmunity in the TEDDY Study. JAMA Pediatr 170:20\u201328","journal-title":"JAMA Pediatr"},{"key":"1873_CR140","doi-asserted-by":"crossref","first-page":"803","DOI":"10.20452\/pamw.3156","volume":"125","author":"MA Kasinska","year":"2015","unstructured":"Kasinska MA, Drzewoski J (2015) Effectiveness of probiotics in type 2 diabetes: a meta-analysis. Pol Arch Med Wewn 125:803\u2013813","journal-title":"Pol Arch Med Wewn"},{"key":"1873_CR141","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4161\/gmic.26749","volume":"5","author":"JF Brugere","year":"2014","unstructured":"Brugere JF, Borrel G, Gaci N, Tottey W, O\u2019Toole PW, Malpuech-Brugere C (2014) Archaebiotics: proposed therapeutic use of archaea to prevent trimethylaminuria and cardiovascular disease. Gut Microbes 5:5\u201310","journal-title":"Gut Microbes"},{"key":"1873_CR142","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/nm0896-883","volume":"2","author":"S Prakash","year":"1996","unstructured":"Prakash S, Chang TM (1996) Microencapsulated genetically engineered live E. coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats. Nat Med 2:883\u2013887","journal-title":"Nat Med"},{"key":"1873_CR143","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/JME-16-0054","volume":"58","author":"S Zhao","year":"2017","unstructured":"Zhao S, Liu W, Wang J, Shi J, Sun Y, Wang W, Ning G, Liu R, Hong J (2017) Akkermansia muciniphila improves metabolic profiles by reducing inflammation in chow diet-fed mice. J Mol Endocrinol 58:1\u201314","journal-title":"J Mol Endocrinol"},{"key":"1873_CR144","doi-asserted-by":"crossref","first-page":"17468","DOI":"10.18632\/oncotarget.8160","volume":"7","author":"YQ Zeng","year":"2016","unstructured":"Zeng YQ, Dai Z, Lu F, Lu Z, Liu X, Chen C, Qu P, Li D, Hua Z, Qu Y, Zou C (2016) Emodin via colonic irrigation modulates gut microbiota and reduces uremic toxins in rats with chronic kidney disease. Oncotarget 7:17468\u201317478","journal-title":"Oncotarget"},{"key":"1873_CR145","doi-asserted-by":"publisher","first-page":"e100778","DOI":"10.1371\/journal.pone.0100778","volume":"9","author":"A Napolitano","year":"2014","unstructured":"Napolitano A, Miller S, Nicholls AW, Baker D, Van Horn S, Thomas E, Rajpal D, Spivak A, Brown JR, Nunez DJ (2014) Novel gut-based pharmacology of metformin in patients with type 2 diabetes mellitus. PLoS ONE 9:e100778","journal-title":"PLoS ONE"},{"key":"1873_CR146","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1681\/ASN.2014060530","volume":"26","author":"E Mishima","year":"2015","unstructured":"Mishima E, Fukuda S, Shima H, Hirayama A, Akiyama Y, Takeuchi Y, Fukuda NN, Suzuki T, Suzuki C, Yuri A, Kikuchi K, Tomioka Y, Ito S, Soga T, Abe T (2015) Alteration of the intestinal environment by lubiprostone is associated with amelioration of adenine-induced CKD. J Am Soc Nephrol 26:1787\u20131794","journal-title":"J Am Soc Nephrol"},{"key":"1873_CR147","first-page":"S23S28","volume":"62","author":"T Niwa","year":"1997","unstructured":"Niwa T, Nomura T, Sugiyama S, Miyazaki T, Tsukushi S, Tsutsui S (1997) The protein metabolite hypothesis, a model for the progression of renal failure: an oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients. Kidney Int Suppl 62:S23\u2013S28","journal-title":"Kidney Int Suppl"},{"key":"1873_CR148","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.2215\/CJN.01650211","volume":"6","author":"JF Navarro-Gonzalez","year":"2011","unstructured":"Navarro-Gonzalez JF, Mora-Fernandez C, Muros de Fuentes M, Donate-Correa J, Cazana-Perez V, Garcia-Perez J (2011) Effect of phosphate binders on serum inflammatory profile, soluble CD14, and endotoxin levels in hemodialysis patients. Clin J Am Soc Nephrol 6:2272\u20132279","journal-title":"Clin J Am Soc Nephrol"},{"key":"1873_CR149","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/nep.12580","volume":"21","author":"RJ Ellis","year":"2016","unstructured":"Ellis RJ, Small DM, Vesey DA, Johnson DW, Francis R, Vitetta L, Gobe GC, Morais C (2016) Indoxyl sulphate and kidney disease: causes, consequences and interventions. Nephrology (Carlton) 21:170\u2013177","journal-title":"Nephrology (Carlton)"},{"key":"1873_CR150","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.trsl.2016.04.007","volume":"179","author":"A Nallu","year":"2017","unstructured":"Nallu A, Sharma S, Ramezani A, Muralidharan J, Raj D (2017) Gut microbiome in chronic kidney disease: challenges and opportunities. Transl Res 179:24\u201337","journal-title":"Transl Res"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-018-1873-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-018-1873-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-018-1873-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T04:41:14Z","timestamp":1751604074000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-018-1873-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,4]]},"references-count":150,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["1873"],"URL":"https:\/\/doi.org\/10.1007\/s11255-018-1873-2","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,4]]},"assertion":[{"value":"16 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of \u0131nterest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}